Adicet Bio

ACET65

Penny Stock

$1.46arrow_drop_down2.66%-$0.04

Penny Stock

ACET65

$1.46

arrow_drop_down2.66%-$0.04

Penny Stock

Performance History

Key Stats
Open	$1.50
Prev. Close	$1.50
EPS	-2.54
Dividend	Non-Dividend
Next Earnings Date	-
Dividend Yield %	-
Market Cap	$123.60M
PE Ratio	-

	LOW	HIGH
Day Range	1.48	1.54
52 Week Range	1.05	3.77

Ratios

Revenue	-



EBITDA Margin %	-

EPS	-2.54

Score Breakdown

Welcome to Stocklytics

Don't miss out on the opportunity to stay ahead in the ever-changing world of finance.

Analyst Forecast

Period: Next 12 Months

•

Analyst Ratings

•

About Adicet Bio (ACET)

Adicet Bio, Inc. (NASDAQ: ACET) is a biotechnology company that focuses on the development of cell-based immunotherapies for the treatment of cancer. The company's proprietary technology platform allows for the engineering of immune cells to specifically target and kill cancer cells. Adicet Bio's lead product candidate, ADI-001, is a chimeric antigen receptor T-cell (CAR-T) therapy targeting CD20 for the treatment of non-Hodgkin lymphoma. The company is also developing additional product candidates targeting other cancer types, including solid tumors.

Adicet Bio's stock price history has shown volatility since its initial public offering (IPO) in 2020. The stock has experienced fluctuations in response to news and events related to the company's clinical trials, regulatory approvals, and partnerships. It is important for investors to carefully analyze these factors and consider the long-term potential of Adicet Bio's technology and product pipeline before making investment decisions.

Websitecall_made

Sector: Healthcare
Industry: Biotechnology
CEO: Mr. Chen Schor BA, CPA, CPA, M.B.A., MBA
Headquarters: Boston
Employees: 132
Exchange: NASDAQ

Keep an eye on Adicet Bio

Adding the right stocks to your watchlist can provide valuable insights and opportunities for strategic decision-making.

Frequently Asked Questions

help

What is Adicet Bio's (ACET) price per share?

The current price per share for Adicet Bio (ACET) is $1.46. The stock has seen a price change of -$0.04 recently, indicating a -2.67% change. This reflects the stock's recent market performance and investor sentiment.

help

What is the 52-week high and low for Adicet Bio (ACET)?

For Adicet Bio (ACET), the 52-week high is $3.77, which is 158.22% from the current price. The 52-week low is $1.05, the current price is 39.05% above the 52-week low. This gives investors an insight into the stock's volatility and price range over the past year.

help

Is Adicet Bio (ACET) a growth stock?

Adicet Bio (ACET) has shown an average price growth of 0.41% over the past three years. It has received a score of 9 out of 100 based on the Stocklytics formula. The interpretation of this score in terms of classifying Adicet Bio as a growth stock may vary, considering it is one of many factors investors might evaluate, including market trends, financial performance, and future prospects of the company.

help

What is Adicet Bio (ACET) stock price performance year to date (YTD)?

As of the latest data, Adicet Bio (ACET) has a year-to-date price change of -27.36%. Over the past month, the stock has experienced a price change of -5.81%. Over the last three months, the change has been 10.61%. Over the past six months, the figure is -25.13%.

help

Is Adicet Bio (ACET) a profitable company?

Adicet Bio (ACET) has a net income of -$142.66M, which represents the company's total earnings after all expenses have been deducted from revenues. The gross margin of indicates the percentage of revenue that exceeds the cost of goods sold, and the operating margin of 0% reflects the percentage of revenue remaining after covering variable production costs, highlighting the efficiency of the company's core operations. Total revenue stands at , although specific revenue growth data is currently not available. Operating income is noted at -$132.58M. Furthermore, the EBITDA is -$121.5M.

help

What is the market capitalization of Adicet Bio (ACET)?

Adicet Bio (ACET) has a market capitalization of $123.6M. The average daily trading volume is 448.68K, indicating the stock's liquidity and investor engagement.